Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
Radoslaw Kaczmarek, Researcher at IU School of Medicine and Hirszfeld Institute, shared an insightful review on X, reposting from The Video Journal of Hematology and Hematological Oncology:
”Thank you for having me The Video Journal of Hematology and Hematological Oncology.
Several colleagues and I also published a reflective article on this:
I summarized some key points in the video.
SPOILER ALERT
It is not due to lack of interest in gene therapy.”
Read the full article here.
Article: Why is the uptake of gene therapy in hemophilia less than expected?
Authors: Glenn F. Pierce, Mark Skinner, Brian O’Mahony, Dawn Rotellini, Radoslaw Kaczmarek
The Video Journal of Hematology and Hematological Oncology shared on X:
”Why has the uptake of gene therapy in hemophilia been less than expected? Is there limited interest in these therapies?
We caught up with Radoslaw Kaczmarek of Indiana University School of Medicine to get the answers to these questions.”
Watch the full interview.
Stay informed on all scientific advances in the field of genetics with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25